All In MedTech

Device Trial Radar · NCT04801771

Effects of Hypoglossal Nerve Stimulation on Cognition and Language in Down Syndrome and Obstructive Sleep Apnea

Last checked: Nov 20, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

57

Actual

Start

Jun 24, 2021

Primary completion

Jul 1, 2026

Study completion Sep 30, 2026

Sponsor

Lead sponsor
Inspire Medical Systems, Inc.Public (INSP)
Sponsor type
Industry
Collaborators
National Institutes of Health (NIH); National Institute on Deafness and Other Communication Disorders (NIDCD)
First posted
Mar 17, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 10 years, up to 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a prospective, single-arm study conducted under a common implant and follow-up protocol. The objective will be to follow fifty-seven (57) adolescents and young adults (10-21 years of age), with Down syndrome, moderate to severe sleep apnea, and post-adenotonsillectomy, for 12 months after undergoing implant of the Inspire Upper Airway Stimulation (UAS) System. The study is being conducted in order to evaluate objective change in cognition and expressive language after implant and therapy with the Inspire UAS System.

Conditions

  • Down Syndrome
  • Obstructive Sleep Apnea

Interventions

  • Inspire Upper Airway Stimulation (UAS) SystemDevice

    The Inspire UAS System is an implantable device that provides hypoglossal nerve stimulation for the treatment of obstructive sleep apnea.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in intelligence using the Kaufman Brief Intelligence Scale (KBIT-2)Time frame: 6 Months post-implant
  2. Change in attention using the Wechsler Intelligence ScaleTime frame: 6 Months post-implant
  3. Change in processing speed using the Cambridge Neuropsychological Test Automated Battery (CANTAB)Time frame: 6 Months post-implant

3 more outcomes with a free account

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Healthcare of Atlanta/ Emory University School of Medicine

    Atlanta, Georgia

  • Massachusetts General Hospital (Mass Eye & Ear Infirmary)

    Boston, Massachusetts

  • Cincinnati Childrens Hospital

    Cincinnati, Ohio

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.